COMPANY
Akston Biosciences Corporation
Founded in Beverly, Massachusetts, Akston is an animal health biotech focusing on developing protein-based therapies for companion animals. SHREVEPORT, La.; Akston, a biotechnology company focused on animal health, has opened a new manufacturing facility as part of a $7 million investment in Caddo Parish to expand its U.S. manufacturing capabilities and strengthen Louisiana’s life sciences sector. From company website Source · Oct 12, 2026
NIH awards 6
- NIH award 5R44DK107099-05 FY2020: $923,642 awarded for that fiscal year; activity R44 (SBIR); PI ZION, TODD C; recipient as written: AKSTON BIOSCIENCES CORPORATION, BEVERLY, MA. IND-enabling assay validation and toxi source ↗
- NIH award 2R44DK107099-04 FY2019: $978,643 awarded for that fiscal year; activity R44 (SBIR); PI ZION, TODD C; recipient as written: AKSTON BIOSCIENCES CORPORATION, BEVERLY, MA. IND-enabling assay validation and toxi source ↗
- NIH award 5R44DK107099-03 FY2018: $998,998 awarded for that fiscal year; activity R44 (SBIR); PI ZION, TODD C; recipient as written: AKSTON BIOSCIENCES CORPORATION, BEVERLY, MA. Selective Depletion of Insulin-Specifi source ↗
- NIH award 2R44DK107099-02 FY2017: $998,123 awarded for that fiscal year; activity R44 (SBIR); PI ZION, TODD C; recipient as written: AKSTON BIOSCIENCES CORPORATION, BEVERLY, MA. Selective Depletion of Insulin-Specifi source ↗
- NIH award 1R43DK107099-01 FY2015: $249,821 awarded for that fiscal year; activity R43 (SBIR); PI ZION, TODD C; recipient as written: AKSTON BIOSCIENCES CORPORATION, BEVERLY, MA. Selective Removal of Insulin-Specific source ↗
- NIH award 1R43AG047706-01 FY2014: $249,926 awarded for that fiscal year; activity R43 (SBIR); PI ZION, TODD C; recipient as written: AKSTON BIOSCIENCES CORPORATION, BEVERLY, MA. Novel Compounds for Reducing Brain A-B source ↗